Fwd: Pain Killers Improve Metabolic Health and Longevity; CHMP Positive About Muscular Dystrophy Drug

Sent from my iPad

Begin forwarded message:

From: Kent Castle <kent.d.castle@hotmail.com>
Date: May 24, 2014 5:50:16 PM CDT
To: Reason Marilou <loganlou55@yahoo.com>, Bogan Carole <bcbogan@earthlink.net>, Patterson James <w8ljz@aol.com>, Astrology Valkyrie <astrogoddess@valkyrieastrology.com>, Madsen Ron <ronstar@pdq.net>, Martin Bobby <bobbygmartin1938@gmail.com>, Matthews-Schmidt Linda <linda.j.matthews-schmidt@nasa.gov>, Kelley Mary <mary.n.kelley@nasa.gov>, Stringer Suzan <suzan.f.stringer@nasa.gov>, Chamberlain Sharon <sharon.m.chamberlain@saic.com>, Williams Tom <gtomwill@att.net>, Heidel TQ <bheidel@highland.net>, Delwood James <jamesdelwood@clear.net>
Subject: FW: Pain Killers Improve Metabolic Health and Longevity; CHMP Positive About Muscular Dystrophy Drug

 

---

From: reply@mail.dddmag.com
To: KENT.D.CASTLE@HOTMAIL.COM
Subject: Pain Killers Improve Metabolic Health and Longevity; CHMP Positive About Muscular Dystrophy Drug
Date: Fri, 23 May 2014 13:01:33 -0600
Interesting pain and itch antibody found --------------------------------------
FDA Clears Kick Off of Phase 3 Alzheimer's Disease Study; Viking Signs Licensing Deal for Novel Therapeutic Programs

View this email in your browser. MAY 23 IN THIS ISSUE   NEWS     CHMP Positive About Muscular Dystrophy Drug     NEWS     FDA Clears Kick Off of Phase 3 Alzheimer's Disease Study     NEWS     Viking Signs Licensing Deal for Novel Therapeutic Programs     NEWS     One Molecule Blocks Both Pain and Itching     NEWS     Biologics Formulation Summit Highlights Best Practices   Read Waters Beginner's Guide to SPE The Beginner's Guide to SPE is a must read for anyone starting out in analytical chromatography or seasoned chemists looking to add solid-phase extraction to their skill set. LEARN MORE FEATURED STORY Pain Killers Improve Metabolic Health and Longevity Blocking a pain receptor in mice not only extends their lifespan, suggesting that pain might drive the aging process, it also gives them a more youthful metabolism, including an improved insulin response that allows them to deal better with high blood sugar. Read more... Share FULL STORY UPLC AND HPLC COLUMNS FOR GLYCAN ANALYSIS Waters now offers both UPLC and HPLC, BEH-based columns for analyzing labeled, N-linked glycans from biotherapeutic proteins. Chromatographers can now choose the most appropriate LC-based technology to address their specific released glycan analysis application needs and laboratory instrumentation. LEARN MORE NEWS CHMP Positive About Muscular Dystrophy Drug PTC Therapeutics Inc. announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the company's application for a conditional marketing authorization of Translarna (ataluren) for the treatment of Duchenne muscular dystrophy. Read more... FULL STORY NEWS FDA Clears Kick Off of Phase 3 Alzheimer's Disease Study AZTherapies Inc., a company developing novel treatments for Alzheimer's disease based on technology licensed from Massachusetts General Hospital, announced that it has received notice from FDA that it may proceed with the Phase 3 clinical study submitted in its IND application. Read more... FULL STORY Maverick Isotyped Immunogenicity Assay The Maverick MT-ADA assay simplifies immunogenicity testing by combining screening, confirmatory, and isotyping tiers into a single assay providing real-time detection of anti-drug antibodies. MORE INFO NEWS Viking Signs Licensing Deal for Novel Therapeutic Programs Viking Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, announced that it has obtained an exclusive worldwide license to five therapeutic programs from Ligand Pharmaceuticals. Read more... FULL STORY NEWS One Molecule Blocks Both Pain and Itching Duke University researchers have found an antibody that simultaneously blocks the sensations of pain and itching by targeting the voltage-sensitive sodium channels in the cell membrane of neurons in studies with mice. Read more...      FULL STORY NEWS Biologics Formulation Summit Highlights Best Practices Freeslate Inc., a provider of high throughput research solutions for biopharmaceutical development, announced highlights of its Biologics Formulation Summit held at Janssen Pharmaceutical in Malvern, Pennsylvania. Read more...        FULL STORY NEWS Novartis to Show Key Advances in Cancer Research Novartis is showcasing the results of research efforts to target disease pathways at upcoming cancer-focused meetings, including updated data in ALK+ non-small cell lung cancer and the first-ever presentations of key data in polycythemia vera, multiple myeloma  and locally advanced or metastatic basal cell carcinoma. Read more... FULL STORY SUBSCRIBE • UNSUBSCRIBE • ABOUT US • ADVERTISE This email was sent by: Drug Discovery & Development 100 Enterprise Drive - Suite 600 - Rockaway, NJ 07866-2129 We respect your right to privacy - click here to view our policy. ©2014 Drug Discovery & Development. All rights reserved.